Literature DB >> 30055536

Cardiovascular Pathologies Associated with Excessive Energy Drink Consumption: A Review.

Azhar Hussain1, Aravindakshan K Jiji2, Prajna Barke2, Suvra Biswas2, Shams S M Tabrez3.   

Abstract

Energy drink consumption has caused worldwide concern in the scientific community and the general public regarding the health effects of these products. Current studies offer data about consumption patterns in America and Europe, but more extensive research is needed to ascertain the potential effects of energy drink consumption, especially among young and healthy individuals. To examine the consequences and health risks of energy drink consumption, related studies were reviewed. Health issues, including elevated blood pressure, palpitations, insomnia, jitters, and nervousness, are primarily associated with high caffeine content. Although more studies examine the effects of highly carbonated and caffeinated products, research determining the health effects of energy drinks is also important. Currently, the evidence regarding the adverse health effects of energy drinks is growing. Unfortunately, the risks of high consumption of energy drinks have not been properly addressed. Thus, these adverse effects may pose a great public health dilemma in the years to come.

Entities:  

Mesh:

Year:  2018        PMID: 30055536     DOI: 10.1615/CritRevEukaryotGeneExpr.2018021703

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  2 in total

1.  Impact of AmaTea® Max on physiological measures and gaming performance in active gamers: A placebo-controlled, double-blind, randomized study.

Authors:  Richard J Bloomer; Keith R Martin; Jacquelyn C Pence
Journal:  J Clin Transl Res       Date:  2022-03-01

2.  Energy Drinks and Their Acute Effects on Arterial Stiffness in Healthy Children and Teenagers: A Randomized Trial.

Authors:  Pengzhu Li; Guido Mandilaras; André Jakob; Robert Dalla-Pozza; Nikolaus Alexander Haas; Felix Sebastian Oberhoffer
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.